Multi-ethnic analysis reveals soluble L-selectin may be post-transcriptionally regulated by 3'UTR polymorphism: the Multi-Ethnic Study of Atherosclerosis (MESA)
- PMID: 25576479
- PMCID: PMC4355192
- DOI: 10.1007/s00439-014-1527-0
Multi-ethnic analysis reveals soluble L-selectin may be post-transcriptionally regulated by 3'UTR polymorphism: the Multi-Ethnic Study of Atherosclerosis (MESA)
Abstract
L-Selectin is constitutively expressed on leukocytes and mediates their interaction with endothelial cells during inflammation. Previous studies on the association of soluble L-selectin (sL-selectin) with cardiovascular disease (CVD) are inconsistent. Genetic variants associated with sL-selectin levels may be a better surrogate of levels over a lifetime. We explored the association of genetic variants and sL-selectin levels in a race/ethnicity stratified random sample of 2,403 participants in the Multi-Ethnic Study of Atherosclerosis (MESA). Through a genome-wide analysis with additive linear regression models, we found that rs12938 on the SELL gene accounted for a significant portion of the protein level variance across all four races/ethnicities. To evaluate potential additional associations, elastic net models were used for variants located in the SELL/SELP/SELE genetic region and an additional two SNPs, rs3917768 and rs4987361, were associated with sL-selectin levels in African Americans. These variants accounted for a portion of protein variance that ranged from 4 % in Hispanic to 14 % in African Americans. To investigate the relationship of these variants with CVD, 6,317 subjects were used. No significant association was found between any of the identified SNPs and carotid intima-media thickness or presence of carotid plaque using linear and logistic regression, respectively. Similarly no significant results were found for coronary artery calcium or coronary heart disease events. In conclusion, we found that variants within the SELL gene are associated with sL-selectin levels. Despite accounting for a significant portion of the protein level variance, none of the variants was associated with clinical or subclinical CVD.
Conflict of interest statement
Figures
References
-
- Battle A, Mostafavi S, Zhu X, Potash JB, Weissman MM, McCormick C, Haudenschild CD, Beckman KB, Shi J, Mei R, Urban AE, Montgomery SB, Levinson DF, Koller D. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 2014;24:14–24. doi: 10.1101/gr.155192.113. - DOI - PMC - PubMed
-
- Berardi C, Decker PA, Kirsch PS, de Andrade M, Tsai MY, Pankow JS, Sale MM, Sicotte H, Tang W, Hanson N, Polak JF, Bielinski SJ. Plasma and serum L-selectin and clinical and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA) Transl Res. 2014;163:585–592. doi: 10.1016/j.trsl.2014.02.001. - DOI - PMC - PubMed
-
- Bielinski SJ, Pankow JS, Li N, Hsu FC, Adar SD, Jenny NS, Bowden DW, Wasserman BA, Arnett D. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA) Atherosclerosis. 2008;201:339–344. doi: 10.1016/j.atherosclerosis.2008.02.031. - DOI - PMC - PubMed
-
- Bielinski SJ, Reiner AP, Nickerson D, Carlson C, Bailey KR, Thyagarajan B, Lange LA, Boerwinkle EA, Jacobs DR, Jr, Gross MD. Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1) Atherosclerosis. 2011;216:390–394. doi: 10.1016/j.atherosclerosis.2011.02.018. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- P50 ES015915/ES/NIEHS NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- N01 HC-95159/HC/NHLBI NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- DK063491/DK/NIDDK NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- UL1TR000124/TR/NCATS NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- RR-024156/RR/NCRR NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- R01HL98077/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01 HL098077/HL/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- KL2 TR001874/TR/NCATS NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- N01-HC-95167/HC/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
